XOMAP (STOCKS)
XOMA Royalty Corporation 8.625% Series A Cumulative Perpetual Preferred Stock
$25.460000
-0.060000 (-0.24%)
Prev close: $25.520000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Owen Patrick Hughes
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $737.77M
- Employees
- 13
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $48.56M |
| Benefits Costs and Expenses | $14.64M |
| Costs And Expenses | $14.64M |
| Operating Expenses | $43.58M |
| Research and Development | $468.00K |
| Other Operating Expenses | $43.11M |
| Operating Income/Loss | $4.98M |
| Income/Loss From Continuing Operations After Tax | $33.81M |
| Income/Loss From Continuing Operations Before Tax | $33.91M |
| Income Tax Expense/Benefit | $104.00K |
| Net Income/Loss | $33.81M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $33.81M |
| Net Income/Loss Available To Common Stockholders, Basic | $23.62M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $16.14M |
| Preferred Stock Dividends And Other Adjustments | $10.19M |
| Undistributed Earnings/Loss Allocated To Participating Securities, Basic | $8.27M |
| Basic Earnings Per Share | $1.65 |
| Diluted Earnings Per Share | $1.57 |
| Basic Average Shares | 12,006,000 |
| Diluted Average Shares | 17,618,000 |
| Assets | $271.86M |
| Current Assets | $118.75M |
| Noncurrent Assets | $153.11M |
| Fixed Assets | $18.00K |
| Intangible Assets | $43.86M |
| Other Non-current Assets | $109.23M |
| Liabilities | $158.96M |
| Current Liabilities | $33.08M |
| Accounts Payable | $3.53M |
| Other Current Liabilities | $29.54M |
| Noncurrent Liabilities | $125.89M |
| Redeemable Noncontrolling Interest | $20.02M |
| Redeemable Noncontrolling Interest, Preferred | $20.02M |
| Equity | $92.88M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $92.88M |
| Temporary Equity | $20.02M |
| Liabilities And Equity | $271.86M |
| Net Cash Flow From Operating Activities | $6.79M |
| Net Cash Flow From Operating Activities, Continuing | $6.79M |
| Net Cash Flow From Investing Activities | $64.13M |
| Net Cash Flow From Investing Activities, Continuing | $64.13M |
| Net Cash Flow From Financing Activities | -$27.21M |
| Net Cash Flow From Financing Activities, Continuing | -$27.21M |
| Net Cash Flow | $43.72M |
| Net Cash Flow, Continuing | $43.72M |
| Comprehensive Income/Loss | $33.81M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $33.81M |
| Other Comprehensive Income/Loss | $6.00K |